Holen Sie sich die Stockscreener-App
6.14
4.66%
-0.30
Handel nachbörslich:
6.09
-0.05
-0.81%
Schlusskurs vom Vortag:
$6.44
Offen:
$6.31
24-Stunden-Volumen:
60,482
Relative Volume:
0.52
Marktkapitalisierung:
$72.37M
Einnahmen:
$52.29M
Nettoeinkommen (Verlust:
$-73.52M
KGV:
-9.303
EPS:
-0.66
Netto-Cashflow:
$-100.45M
1W Leistung:
-24.75%
1M Leistung:
+8.10%
6M Leistung:
+18.53%
1J Leistung:
-27.08%
1-Tages-Spanne:
$6.07
$6.3243
1-Wochen-Bereich:
$6.07
$7.74
52-Wochen-Spanne:
$3.61
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
Firmenname
Precision Biosciences Inc
Sektor
Branche
Telefon
919-314-5512
Adresse
302 EAST PETTIGREW STREET, DURHAM, NC
Vergleichen Sie DTIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
6.14 | 85.37M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Eingeleitet | Guggenheim | Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-09 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Fortgesetzt | BTIG Research | Buy |
| 2020-04-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Stifel | Buy |
| 2020-02-25 | Eingeleitet | William Blair | Outperform |
| 2019-08-09 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-22 | Eingeleitet | Barclays | Overweight |
| 2019-04-22 | Eingeleitet | Goldman | Buy |
| 2019-04-22 | Eingeleitet | JP Morgan | Overweight |
| 2019-04-22 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunityEarnings Trend Report & Weekly Stock Breakout Alerts - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidateMarket Sentiment Report & Growth Focused Stock Reports - newser.com
Has Precision BioSciences Inc. found a price floor2025 Big Picture & Technical Buy Zone Confirmation - newser.com
Is Precision BioSciences Inc. stock gaining market shareJuly 2025 PostEarnings & Weekly Market Pulse Alerts - newser.com
How hedge fund analytics apply to Precision BioSciences Inc. stockProduct Launch & Verified High Yield Trade Plans - newser.com
How Precision BioSciences Inc. stock trades during market volatilityTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
Multi asset correlation models including Precision BioSciences Inc.Earnings Summary Report & Safe Capital Growth Stock Tips - newser.com
Momentum divergence signals in Precision BioSciences Inc. chartJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
Is Precision BioSciences Inc. stock a defensive play in 2025Market Trend Report & AI Enhanced Trading Signals - newser.com
Earnings visualization tools for Precision BioSciences Inc.Watch List & Weekly Breakout Stock Alerts - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIJuly 2025 Movers & Precise Swing Trade Entry Alerts - newser.com
Using economic indicators to assess Precision BioSciences Inc. potentialJuly 2025 Intraday Action & Expert Verified Movement Alerts - newser.com
Stock Analysis: Why Precision BioSciences Inc. stock is a value investor pickQuarterly Portfolio Review & AI Powered Buy/Sell Recommendations - fcp.pa.gov.br
What analysts say about Precision BioSciences Inc stockAnalyst Downgrades & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
Top Analysts Predictions for Npl Chemicals Limited Stock Over 12 MonthsTrade Execution Strategies & Unlock Patterns Humans Can’t See - earlytimes.in
Precision BioSciences (NASDAQ:DTIL) CEO Sells $22,124.41 in Stock - MarketBeat
Imugene Issues Shares to Precision Biosciences Following Milestone Achievement - MSN
symbol__ Stock Quote Price and Forecast - CNN
Precision BioSciences Reports Q3 2025 Financial Results - TipRanks
Will Precision BioSciences Inc. outperform the marketJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Can Precision BioSciences Inc. stock resist market sell offsEntry Point & Verified Technical Trade Signals - newser.com
Is Precision BioSciences Inc. stock positioned well for digital economyCEO Change & Free AI Powered Buy and Sell Recommendations - newser.com
Real time breakdown of Precision BioSciences Inc. stock performanceTrade Analysis Report & Verified Swing Trading Watchlists - newser.com
Precision Biosciences CEO Sells Shares to Cover Tax Obligations - TradingView
[Form 4] PRECISION BIOSCIENCES INC Insider Trading Activity - Stock Titan
Precision BioSciences (NASDAQ:DTIL) Announces Quarterly Earnings Results - MarketBeat
Precision BioSciences: Q3 Earnings Snapshot - CT Insider
Is Precision BioSciences Inc. (PBS0) stock prepared for digital transitionTrade Entry Summary & High Accuracy Trade Alerts - newser.com
Precision BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Precision BioSciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus
Precision BioSciences Inc Reports Q3 2025 EPS of -$1.84, Missing - GuruFocus
Precision BioSciences Q3 revenue falls sharply - MarketScreener
PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView
Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire
[8-K] PRECISION BIOSCIENCES INC Reports Material Event | DTIL SEC FilingForm 8-K - Stock Titan
Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - MarketScreener
Finanzdaten der Precision Biosciences Inc-Aktie (DTIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.44%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):